Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

14-3-3ζ蛋白诱导NK/T细胞淋巴瘤吉西他滨耐药的机制研究

伊布替尼联合CAR-T治疗BCL-2抑制剂耐药伴del(17p)慢性淋巴细胞白血病一例报告并文献复习

成人急性淋巴细胞白血病患者首疗程化疗结束时微小残留病检测对自体造血干细胞移植预后的意义

尼洛替尼暴露对女性慢性髓性白血病患者妊娠结局的影响

同种异基因CAR-T细胞治疗复发/难治多发性骨髓瘤四例临床观察并文献复习

青少年和成人急性T淋巴细胞白血病/淋巴瘤126例临床分析及急性早期前体T淋巴细胞白血病/淋巴瘤分型预后意义的初步探讨

[Efficacy and safety of domestic dasatinib as second-line treatment for chronic myeloid leukemia patients in the chronic phase].

[Fertility and disease outcomes in patients with chronic myeloid leukemia].

化疗联合异基因自然杀伤细胞巩固治疗低中危急性髓系白血病的疗效观察

单倍型造血干细胞移植后闭塞性细支气管炎综合征的临床分析

青蒿琥酯联合硼替佐米对急性髓系白血病细胞体外凋亡、自噬的影响及其作用机制

利妥昔单抗联合化疗治疗229例滤泡性淋巴瘤患者的预后研究

化疗联合供者淋巴细胞输注对异基因造血干细胞移植后微小残留病阳性患者慢性移植物抗宿主病及预后的影响

单倍型与同胞全相合造血干细胞移植治疗阵发性睡眠性血红蛋白尿症疗效比较

原发与继发甲状腺淋巴瘤的临床特征和预后比较

异基因造血干细胞移植治疗骨髓增生异常综合征的预后因素分析

[The efficacy analysis of allogeneic hematopoietic stem cell transplantation in 48 leukemia patients with central nervous system leukemia].

大剂量美法仑与环磷酰胺、依托泊苷联合白消安预处理方案在多发性骨髓瘤自体造血干细胞移植中的比较

尼洛替尼与伊马替尼一线治疗初发慢性髓性白血病患者的比较研究

HLA-10/10相合无关供者与同胞供者造血干细胞移植治疗成人急性髓系白血病疗效比较

RUNX1-RUNX1T1融合转录本及WT1转录本水平检测的室间比对研究

结合人口学特征比较国产和原研伊马替尼治疗慢性髓性白血病慢性期患者的有效性和安全性

传统免疫化疗时代118例TP53基因异常慢性淋巴细胞白血病患者生存分析

造血干细胞移植治疗血管免疫母细胞性T细胞淋巴瘤临床分析

抗髓鞘相关糖蛋白抗体阳性IgM相关性周围神经病11例临床分析

脐血间充质干细胞在难治性重型再生障碍性贫血异基因造血干细胞移植中的应用

实体肿瘤病史对弥漫大B细胞淋巴瘤患者的疗效和生存的影响

[Analysis of clinical characteristics, treatment response rate and survival of 77 myelodysplastic syndrome patients with del (5q) syndrome].

[Prognostic evaluation of P53 and BCL2 proteins in MYC/BCL2 double expression DLBCL].

[Expression of CD45 in newly diagnosed multiple myeloma and the relationship with prognosis].

[Adverse effects of double-hit combining ISS-Ⅲ stage and 1q gain or del (17p) on prognosis of patients with newly diagnosed multiple myeloma].

[Comparison of clinical efficacy between first-generation and second-generation tyrosine kinase inhibitors based regimen in the treatment of patients with BCR-ABL positive acute lymphoblastic leukemia].

血液系统疾病合并气单胞菌血流感染患者的临床及实验室特征

[Clinical implication of minimal residual disease monitoring by 10-color flow cytometry in multiple myeloma].

[Therapeutic effect of combined use of interferon alpha-1b, interleukin-2 and thalidomide on reversing minimal residual disease in acute myeloid leukemia].

[Clinical and prognostic values of TP53 mutation in patients with acute myeloid leukemia].

[Analysis of induction efficacy and prognostic factors in FLT3-ITD positive acute myeloid leukemia in the real world].

[A study of clinical characteristics and prognosis of primary myelofibrosis patients with thrombocytopenia in varied degrees].

[Application of multiplex PCR assay to study early multiple herpesviruses infection during HSCT].

[Eltrombopag for the treatment of primary immune thrombocytopenia in 23 pediatric patients].

[The anti-proliferative and anti-inflammatory mechanisms of JAK1 inhibitor SHR0302 versus Ruxolitinib in SET2 cell line and primary cells].

[Mucormycosis in patients with hematological diseases: seven cases reports and literature review].

多核苷酸多态性分析在异基因造血干细胞移植后嵌合状态检测中的应用

[Prognostic value of donor chimerism at +90 days after allogeneic hematopoietic stem cell transplantation in young patients with intermediate-risk acute myeloid leukemia].

GATA2突变相关儿童原发性骨髓增生异常综合征临床及分子生物学特征

过表达CD99后霍奇金淋巴瘤细胞株L428细胞蛋白表达变化的蛋白质组学分析及验证

综合老年学评估在老年急性髓系白血病患者中应用的多中心、前瞻性研究